Atlas Trials

Long-term Follow-up of Subjects Treated With OTL-300 for Transfusion Dependent Beta-thalassemia Study (TIGET-BTHAL)

Clinical trial NCT03275051 · UNKNOWN

Trial details

NCT number
NCT03275051
Sponsor
IRCCS San Raffaele
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Beta Thalassaemia
Start date
2017-10-04
Primary completion
2025-12-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.